Dr. Thatcher Ross Heumann, MD

Dr. Heumann practices at Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center.

Dr. Heumann's NPI, 1649626797, was assigned on May 9, 2016. Dr. Heumann graduated from Emory University School of Medicine in 2016. Dr. Heumann holds Tennessee license 65517.

Dr. Heumann's primary practice is Vanderbilt University Medical Center, at 1211 Medical Center Drive, Nashville, TN 37232 in Davidson County. The practice phone is (615) 322-3454.

Dr. Heumann's primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Dr. Heumann to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Heumann practices, 3 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Heumann's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Heumann is licensed in Tennessee.

CMS data shows 265 Medicare services from Dr. Heumann across 6 procedure codes in 2024, for 99 Medicare patients. Medicare paid $24,223 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 99 Medicare patients who saw Dr. Heumann in 2024. The largest group is 65 to 74, with 47 patients. 75% of them have high blood pressure, and 72% have high cholesterol. Their average risk score is 2.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Heumann's median patient age at 70, with 42% women.

In 2024, Dr. Heumann wrote 225 Medicare Part D claims for 49 patients. 76% of them were for generic drugs. CMS names the drug for 116 of them, across 7 drugs with 11 or more claims each, at $318,232 in total drug cost. In 2023, CMS named 46 claims across 3 drugs.

Dr. Heumann accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Heumann as offering telehealth.

Dmand AI links 16 papers to Dr. Heumann, published from 2015 to 2025. 2023 was the busiest year, with 4. The most frequent topics are Adenocarcinoma, Pancreatic Neoplasms and Bile Duct Neoplasms. Dr. Heumann has published most often in Adv Oncol. Dr. Heumann's most frequent co-authors are Rajiv Agarwal, Laura Williams Goff, MD and Nilofer Saba Azad, MD.

CMS Open Payments shows 8 general payments to Dr. Heumann from 2 drug and device companies in 2023. Consulting fees make up the largest share, 76% of the total. Eisai Inc. paid the most, $7,123.

Dr. Heumann graduated from Emory University School of Medicine in 2016.